+91 9740742752 ||   admissions@hcgcare.org

Dr. Mithua Ghosh

Image

Dr. Mithua Ghosh

Dr. Mithua Ghosh

Dr. Mithua Ghosh is a renowned cancer biologist and the founder of Lorven Biologics. With a strong background in cancer genomics and precision medicine, she has contributed significantly to the understanding of molecular mechanisms driving cancer progression. Her work bridges the gap between genomic research and its clinical applications, particularly in targeted therapies and diagnostics.

She is also actively involved in translational research and collaborations aimed at developing novel diagnostic tools for personalized cancer treatment. Through her leadership, she promotes access to affordable and advanced genomic solutions for cancer patients in India.

  • Qualification: PhD in Cancer Biology / Molecular Oncology
  • Specialty: Cancer Genomics & Molecular Diagnostics
  • Location: Bengaluru, Karnataka, India

Area of Expertise

  • Leadership in developing comprehensive cancer genomics and liquid biopsy platforms including NGS, cytogenetics, and molecular diagnostics
  • Expertise in translational cancer biology including oncogenes, p53 signaling, and cancer stem cell biology in leukemia
  • Extensive experience in corporate R&D across biotech, academic, and pharmaceutical sectors
  • Contributor to biomarker advisory boards and institutional ethics committees

Medical Breakthrough

  • Developed and operationalized Triesta Genomics, HCG’s advanced precision oncology diagnostic platform
  • Enabled genomics-driven cancer treatment across healthcare networks
  • Active role in institutional ethics committees and national biomarker research initiatives
  • Supports advancement of translational oncology through research and advisory contributions

Awards & Accolades

  • Authored numerous peer-reviewed publications on cancer stem cells and tumorigenesis
  • Contributed to biomarker validation through academic and industry research
  • Regular speaker and session chair at national and international oncology conferences
  • Recognized for expertise in cancer genomics and precision medicine
WhatsApp